Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandra Barratt

Showing results (121-130 of 148) with videos related to

Pageof 15
Sort By:
BMJ Open|September 27, 2014
Overdetection in breast cancer screening: development and preliminary evaluation of a decision aidJolyn Hersch, Jesse Jansen, Alexandra Barratt, et al.
Patient Education and Counseling|September 2, 2008
HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choiceKirsten J McCaffery, Les Irwig, Siew Foong Chan, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 18, 2004
Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treatAlexandra Barratt, Peter C Wyer, Rose Hatala, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 10, 2019
The association between induction of labour at 38 to 39 weeks pregnancy and indication for caesarean delivery: An observational studyBradley Stephen de Vries, Kevin McGeechan, Alexandra Barratt, et al.
Annals of Internal Medicine|February 5, 2019
Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example?Katy J L Bell, Jenny Doust, Paul Glasziou, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|December 28, 2018
Outcomes of induction of labour in nulliparous women at 38 to 39 weeks pregnancy by clinical indication: An observational studyBradley Stephen de Vries, Alexandra Barratt, Kevin McGeechan, et al.
Journal of Clinical Epidemiology|April 28, 2022
A novel methodological framework was described for detecting and quantifying overdiagnosisKaty Bell, Jenny Doust, Sharon Sanders, et al.
Respiratory Medicine|January 21, 2026
Impact of carbon footprint information on inhaler prescribing intentions by general practitioners: protocol for an online factorial randomised experimentLuise Kazda, Timothy E Schlub, Michelle Guppy, et al.
Lancet (London, England)|February 22, 2015
Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trialJolyn Hersch, Alexandra Barratt, Jesse Jansen, et al.
Journal of Medical Screening|November 20, 2015
The importance of enabling informed decision making for women considering breast cancer screeningJolyn Hersch, Alexandra Barratt, Jesse Jansen, et al.
Pageof 15

Showing results (121-130 of 148) with videos related to

Sort By:
Pageof 15
BMJ Open|September 27, 2014
Overdetection in breast cancer screening: development and preliminary evaluation of a decision aidJolyn Hersch, Jesse Jansen, Alexandra Barratt, et al.
Patient Education and Counseling|September 2, 2008
HPV testing versus repeat Pap testing for the management of a minor abnormal Pap smear: evaluation of a decision aid to support informed choiceKirsten J McCaffery, Les Irwig, Siew Foong Chan, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|August 18, 2004
Tips for learners of evidence-based medicine: 1. Relative risk reduction, absolute risk reduction and number needed to treatAlexandra Barratt, Peter C Wyer, Rose Hatala, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|July 10, 2019
The association between induction of labour at 38 to 39 weeks pregnancy and indication for caesarean delivery: An observational studyBradley Stephen de Vries, Kevin McGeechan, Alexandra Barratt, et al.
Annals of Internal Medicine|February 5, 2019
Recognizing the Potential for Overdiagnosis: Are High-Sensitivity Cardiac Troponin Assays an Example?Katy J L Bell, Jenny Doust, Paul Glasziou, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|December 28, 2018
Outcomes of induction of labour in nulliparous women at 38 to 39 weeks pregnancy by clinical indication: An observational studyBradley Stephen de Vries, Alexandra Barratt, Kevin McGeechan, et al.
Journal of Clinical Epidemiology|April 28, 2022
A novel methodological framework was described for detecting and quantifying overdiagnosisKaty Bell, Jenny Doust, Sharon Sanders, et al.
Respiratory Medicine|January 21, 2026
Impact of carbon footprint information on inhaler prescribing intentions by general practitioners: protocol for an online factorial randomised experimentLuise Kazda, Timothy E Schlub, Michelle Guppy, et al.
Lancet (London, England)|February 22, 2015
Use of a decision aid including information on overdetection to support informed choice about breast cancer screening: a randomised controlled trialJolyn Hersch, Alexandra Barratt, Jesse Jansen, et al.
Journal of Medical Screening|November 20, 2015
The importance of enabling informed decision making for women considering breast cancer screeningJolyn Hersch, Alexandra Barratt, Jesse Jansen, et al.
Pageof 15